James Monsees Net Worth

Monsees has a degree in product design from Stanford University and has worked in the technology industry for over a decade. James Monsees is an American businessman and entrepreneur with a net worth of $1.1 billion. He is the co-founder and chief product officer of Juul Labs, an electronic cigarette company, which he founded with Adam Bowen. Monsees has a degree in product design from Stanford University and has extensive experience in the technology industry.
James Monsees is a member of Richest Billionaires

Age, Biography and Wiki

Birth Place American

💰 Net worth: $1.1 Billion (2024)

James Monsees, the co-founder of Juul Labs, is projected to have a net worth of approximately $1.1 billion by 2024. With his remarkable success in the e-cigarette industry, Monsees has gained recognition as one of the wealthiest billionaires in America. As a trailblazer in the vaping market, his company revolutionized the way people consume nicotine by introducing sleek and innovative products. Through Juul Labs' exponential growth and widespread popularity, Monsees has significantly contributed to his own fortune, earning him a prominent position in the elite league of American billionaires.

Some James Monsees images

James Monsees net worth: James Monsees is an American businessman and entrepreneur who has a net worth of $1.1 billion. James Monsees is the co-founder and chief product officer of the electronic cigarette company Juul Labs. He co-founded the company with Adam Bowen. Monsees graduated from Whitfield School and earned his BA from Kenyon College and his MS from Stanford University where he studied product design. Altria purchased a 35% stake in Juul in December 2018 which increase his net worth. Juul was formed in 2015 and is headquartered in San Francisco, California. The company had a revenue of $2 billion in 2018 and also employed 1,500 people.  The Juul e-cigarette packages nicotine salts from leaf tobacco into cartridges that have a one time use. It became the most popular e-cigarette in the U.S. but has been subject to multiple investigations by the U.S. Food and Drug Administration partly due to its high nicotine concentrations.